Vojnosanitetski pregled 2023 Volume 80, Issue 7, Pages: 581-586
https://doi.org/10.2298/VSP220130102M
Full text (
294 KB)
Incidence of nonsyndromic congenital heart defects in the Republic of Srpska in the period 2015-2016
Marić Nina (University Clinical Center of the Republic of Srpska, Clinic for Children’s Diseases, Banja Luka, Republic of Srpska, Bosnia and Herzegovina), ninamaric.bl@gmail.com
Predojević-Samardžić Jelica 
(University Clinical Center of the Republic of Srpska, Clinic for Children’s Diseases, Banja Luka, Republic of Srpska, Bosnia and Herzegovina)
Đukić Dario (University Clinical Center of the Republic of Srpska, Clinic for Children’s Diseases, Banja Luka, Republic of Srpska, Bosnia and Herzegovina)
Background/Aim. Congenital heart defect (CHD) is the most common type of birth defect and one of the leading causes of infant mortality. It can be isolated or occur as a part of multiple different syndromes. The reported worldwide incidence of isolated CHD is between 70 and 120 per 10,000 live births. The aim of the study was to estimate the incidence of nonsyndromic C HD in the Republic of Srpska (RS), Bosnia and Herzegovina and compare it with other countries. Methods. The fetuses, live-born and stillborn infants with CHD during 2015 and 2016 in the RS, were analyzed using data from a cross-sectional study. Results. The total incidence of CHD was 163.95 per 10,000 total births, and the incidence of live-born with CHD was 136.64 per 10,000. The diagnosis was established prenatally in 8.09% of cases. The most common type of anomaly was ventricular septal defect (45.63%), followed by an atrial septal defect (31.40%), patent ductus arteriosus (7.44%), and pulmonary valve stenosis (5.18%). A significant difference in the incidence of CHD between regions and different maternal age groups was found. Conclusion. The incidence of CHD in the RS found in this study is higher than in other studies, with marked heterogeneity between different regions. This study provides baseline data for future monitoring of the risk factor changes and the implementation of primary preventive measures.
Keywords: bosnia and herzegovina, fetus, heart defects, congenital, incidence, infant, newborn
Show references
Triedman JK, Newburger JW. Trends in Congenital Heart Disease: The Next Decade. Circulation 2016; 133(25): 2716-33.
Oster ME, Lee KA, Honein MA, Riehle-Colarusso T, Shin M, Correa A. Temporal trends in survival among infants with critical congenital heart defects. Pediatrics 2013; 131(5): e1502-8.
Ferencz C, Boughman JA, Neill CA, Brenner JI, Perry LW. Congenital cardiovascular malformations: Questions on Inheritance. Baltimore-Washington Infant Study Group. J Am Coll Cardiol 1989; 14(3): 756-63.
Hoffman JIE. The global burden of congenital heart disease. Cardiovasc J Afr 2013; 24(4): 141-5.
Van der Linde D, Konings EE, Slager MA, Witsenburg M, Helbing WA, Takkenberg JJ, et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol 2011; 58(21): 2241-7.
Qu Y, Liu X, Zhuang J, Chen G, Mai J, Guo X, et al. Incidence of congenital heart disease: the 9-year experience of the Guangdong registry of congenital heart disease, China. PLoS One 2016; 11(7): e0159257.
EUROCAT. Cases and prevalence (per 10,000 births) for all full member registries from 2011 to 2015 [Internet]. 2015 [accessed on 2023 May 16]. Available from: https://eu-rd-platform.jrc.ec.europa.eu/eurocat/eurocat-data/prevalence_en
Bjornard K, Riehle-Colarusso T, Gilboa SM, Correa A. Patterns in the prevalence of congenital heart defects, metropolitan Atlanta, 1978 to 2005. Birth Defects Res A Clin Mol Teratol 2013; 97(2): 87-94.
Liu Y, Chen S, Zühlke L, Black GC, Choy MK, Li N, et al. Global birth prevalence of congenital heart defects 1970-2017: updated systematic review and meta-analysis of 260 studies. Int J Epidemiol 2019; 48(2): 455-63.
Obeid R, Holzgreve W, Pietrzik K. Folate supplementation for prevention of congenital heart defects and low birth weight: an update. Cardiovasc Diagn Ther 2019; 9(Suppl 2): S424-33.
Jenkins KJ, Correa A, Feinstein JA, Botto L, Britt AE, Daniels SR, et al. Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 2007; 115(23): 2995-3014.
Dolk H. EUROCAT: 25 years of European surveillance of congenital anomalies. Arch Dis Child Fetal Neonatal Ed 2005; 90(5): F355-8.
Reefhuis J, Honein MA. Maternal age and non-chromosomal birth defects, Atlanta 1968-2000: Teenager or thirty-something, who is at risk? Birth Defects Res A Clin Mol Teratol 2004; 70(9): 572-9.
Statistical Yearbook of Republika Srpska 2017 [Internet]. 2017 [cited 2021 September 5]. Available from: https://www.rzs.rs.ba/static/uploads/bilteni/godisnjak/2017/05stn_2017.pdf
Meller CH, Grinenco S, Aiello H, Córdoba A, Sáenz-Tejeira MM, Marantz P, et al. Congenital heart disease, prenatal diagnosis and management. Arch Argent Pediatr 2020; 118(2): e149-61.
Ramaekers P, Mannaerts D, Jacquemyn Y. Re: Prenatal detection of congenital heart disease-results of a national screening programme. BJOG 2015; 122(10): 1420-1.
Van Velzen CL, Clur SA, Rijlaarsdam ME, Bax CJ, Pajkrt CJ, Heymans MW, et al. Prenatal detection of congenital heart disease-results of a national screening programme. BJOG 2016; 123(3): 400-7.
Giraldo-Grueso M, Zarante I, Mejía-Grueso A, Gracia G. Risk factors for congenital heart disease: A case-control study. Rev Colomb Cardiol 2020; 27(4): 324-9.
Hedermann G, Hedley PL, Thagaard IN, Krebs L, Ekelund CK, Sørensen TIA, et al. Maternal obesity and metabolic disorders associated with congenital heart defects in the offspring: A systematic review. PLoS One 2021; 16(5): e0252343.
Su XJ, Yuan W, Huang GY, Olsen J, Li J. Paternal Age and Off-spring Congenital Heart Defects: A National Cohort Study. PLoS One 2015; 10(3): e0121030.
Khairy P, IonescuIttu R, Mackie AS, Abrahamowicz M, Pilote L, Marelli AJ. Changing mortality in congenital heart disease. J Am Coll Cardiol 2010; 56(14): 1149-57.
Miyake T. A review of isolated muscular ventricular septal defect. World J Pediatr 2020; 16(2): 120-8.